Health economic analyses of the justice community opioid innovation network (JCOIN).
Cost-effective
Economics
JCOIN
Justice populations
Opioid use disorder
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
05
09
2020
revised:
01
12
2020
accepted:
14
12
2020
pubmed:
10
1
2021
medline:
14
9
2021
entrez:
9
1
2021
Statut:
ppublish
Résumé
The Justice Community Opioid Innovation Network (JCOIN) will generate real-world evidence to address the unique needs of people with opioid use disorder (OUD) in justice settings. Evidence regarding the economic value of OUD interventions in justice populations is limited. Moreover, the variation in economic study designs is a barrier to defining specific interventions as broadly cost-effective. The JCOIN Health Economics Analytic Team (HEAT) has worked closely with the Measures Committee to incorporate common economic measures and instruments across JCOIN studies, which will: a) ensure rigorous economic evaluations within each trial; b) enhance comparability of findings across studies; and c) allow for cross-study analyses of trials with similar designs/settings (e.g., pre-reentry MOUD), to assess questions beyond the scope of a single study, while controlling for and evaluating the effect of intervention-, organizational-, and population-level characteristics. We describe shared trial characteristics relevant to the economic evaluations, and discuss potential cross-study economic analyses.
Identifiants
pubmed: 33419602
pii: S0740-5472(20)30519-5
doi: 10.1016/j.jsat.2020.108262
pmc: PMC8255321
mid: NIHMS1658651
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108262Subventions
Organisme : NIDA NIH HHS
ID : U2C DA050098
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050065
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050072
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050074
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013035
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA016184
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA050442
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050067
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG069080
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092949
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050071
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050077
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050066
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA050069
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
J Subst Abuse Treat. 2020 Mar;112S:18-27
pubmed: 32220406
J Subst Abuse Treat. 2021 Sep;128:108364
pubmed: 33741216
Front Psychol. 2019 Jun 13;10:1052
pubmed: 31263434
BMC Psychiatry. 2008 Jan 07;8:2
pubmed: 18179700
Addict Sci Clin Pract. 2020 Apr 22;15(1):15
pubmed: 32321570
J Subst Abuse Treat. 2021 Sep;128:108245
pubmed: 33461829
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
J Subst Abuse Treat. 2021 Sep;128:108315
pubmed: 33583610
Health Aff (Millwood). 2017 Dec;36(12):2046-2053
pubmed: 29200340
J Subst Abuse Treat. 2021 Sep;128:108389
pubmed: 33865691
J Clin Epidemiol. 1996 Sep;49(9):989-95
pubmed: 8780606
J Subst Abuse Treat. 2021 Sep;128:108290
pubmed: 33487517
Drug Alcohol Depend. 2010 Apr 1;108(1-2):98-109
pubmed: 20071107
Lancet. 2019 Apr 27;393(10182):1760-1772
pubmed: 30878228
J Subst Abuse Treat. 2021 Sep;128:108277
pubmed: 33487516
Med Care. 1992 May;30(5):400-11
pubmed: 1583918
Am J Epidemiol. 1989 Feb;129(2):233-48
pubmed: 2643301
Child Youth Serv Rev. 2014 Apr 1;39:177-182
pubmed: 24729650
J Subst Abuse Treat. 2021 Sep;128:108275
pubmed: 33483222
J Subst Abuse Treat. 2021 Sep;128:108348
pubmed: 33745757
Pharmacoeconomics. 2016 Sep;34(9):863-87
pubmed: 27002518
J Subst Abuse Treat. 2021 Sep;128:108241
pubmed: 33339633
J Subst Abuse Treat. 1997 Sep-Oct;14(5):445-55
pubmed: 9437614
Med Care. 1999 Jul;37(7):662-70
pubmed: 10424637
J Subst Abuse Treat. 2021 Sep;128:108284
pubmed: 33455828